{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?sponsor=Heron+Therapeutics", "query": { "sponsor": "Heron Therapeutics" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 28, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?sponsor=Heron+Therapeutics&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-09T04:39:59.555Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03718039", "title": "Phase 2 Bunionectomy HTX-011 Administration Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Postoperative Pain" ], "interventions": [ { "name": "HTX-011", "type": "DRUG" }, { "name": "Luer Lock applicator", "type": "DEVICE" }, { "name": "Vial access device", "type": "DEVICE" }, { "name": "aprepitant", "type": "DRUG" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Heron Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 78, "start_date": "2018-10-24", "completion_date": "2019-03-11", "has_results": true, "last_update_posted_date": "2026-03-02", "last_synced_at": "2026-10-09T04:39:59.555Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03718039" }, { "nct_id": "NCT02762929", "title": "Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Postoperative Pain", "Bunions" ], "interventions": [ { "name": "HTX-011A", "type": "DRUG" }, { "name": "Saline Placebo", "type": "BIOLOGICAL" }, { "name": "HTX-011B", "type": "DRUG" }, { "name": "HTX-002", "type": "DRUG" }, { "name": "Bupivacaine HCl", "type": "DRUG" }, { "name": "HTX-009", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Heron Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 430, "start_date": "2016-05", "completion_date": "2017-03", "has_results": true, "last_update_posted_date": "2026-02-23", "last_synced_at": "2026-10-09T04:39:59.555Z", "location_count": 5, "location_summary": "Anaheim, California • Bakersfield, California • Pasadena, Maryland + 2 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Bakersfield", "state": "California" }, { "city": "Pasadena", "state": "Maryland" }, { "city": "Houston", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02762929" }, { "nct_id": "NCT03015532", "title": "Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Postoperative Pain" ], "interventions": [ { "name": "HTX-011", "type": "DRUG" }, { "name": "Saline Placebo", "type": "DRUG" }, { "name": "Bupivicaine HCl", "type": "DRUG" }, { "name": "Ropivacaine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Heron Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 285, "start_date": "2017-01-13", "completion_date": "2018-05-16", "has_results": true, "last_update_posted_date": "2026-03-02", "last_synced_at": "2026-10-09T04:39:59.555Z", "location_count": 24, "location_summary": "Mobile, Alabama • Sheffield, Alabama • Phoenix, Arizona + 13 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Sheffield", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03015532" }, { "nct_id": "NCT06109415", "title": "A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Postoperative Pain", "Total Shoulder Arthroplasty", "Multimodal Analgesia" ], "interventions": [ { "name": "HTX-011", "type": "DRUG" }, { "name": "Bupivacaine Hydrochloride", "type": "DRUG" }, { "name": "Ibuprofen", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Luer lock applicator", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Heron Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2021-10-20", "completion_date": "2022-07-29", "has_results": false, "last_update_posted_date": "2023-10-31", "last_synced_at": "2026-10-09T04:39:59.555Z", "location_count": 5, "location_summary": "Little Rock, Arkansas • Jenks, Oklahoma • Bellaire, Texas + 2 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Jenks", "state": "Oklahoma" }, { "city": "Bellaire", "state": "Texas" }, { "city": "Carrollton", "state": "Texas" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT06109415" }, { "nct_id": "NCT02106494", "title": "A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chemotherapy-induced Nausea and Vomiting" ], "interventions": [ { "name": "APF530", "type": "DRUG" }, { "name": "Ondansetron", "type": "DRUG" }, { "name": "Ondansetron placebo", "type": "DRUG" }, { "name": "APF530 placebo", "type": "DRUG" }, { "name": "Fosaprepitant", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Heron Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "87 Years", "sex": "ALL", "summary": "18 Years to 87 Years" }, "enrollment_count": 942, "start_date": "2014-03", "completion_date": "2015-05", "has_results": true, "last_update_posted_date": "2026-03-02", "last_synced_at": "2026-10-09T04:39:59.555Z", "location_count": 7, "location_summary": "Phoenix, Arizona • Downey, California • Riverside, California + 4 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Downey", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "Mishawaka", "state": "Indiana" }, { "city": "South Bend", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT02106494" }, { "nct_id": "NCT05434663", "title": "Safety Study of Repeat Doses of SUSTOL in Adults", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chemotherapy-Induced Nausea and Vomiting (CINV)" ], "interventions": [ { "name": "SUSTOL", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Heron Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2022-07-06", "completion_date": "2025-10", "has_results": false, "last_update_posted_date": "2023-07-28", "last_synced_at": "2026-10-09T04:39:59.555Z", "location_count": 2, "location_summary": "Hattiesburg, Mississippi • Canton, Ohio", "locations": [ { "city": "Hattiesburg", "state": "Mississippi" }, { "city": "Canton", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05434663" }, { "nct_id": "NCT01416259", "title": "A Phase I Study of the Effects of APF530 Exposure, Granisetron and Moxifloxacin", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Healthy" ], "interventions": [ { "name": "Withdraw treatment", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Heron Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 56, "start_date": "2011-07", "completion_date": "2011-10", "has_results": false, "last_update_posted_date": "2026-02-12", "last_synced_at": "2026-10-09T04:39:59.555Z", "location_count": 1, "location_summary": "West Bend, Wisconsin", "locations": [ { "city": "West Bend", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01416259" }, { "nct_id": "NCT03695367", "title": "Phase 2 Herniorrhaphy Study for Opioid Elimination", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Postoperative Pain" ], "interventions": [ { "name": "HTX-011", "type": "DRUG" }, { "name": "Luer lock applicator", "type": "DEVICE" }, { "name": "Vial access device", "type": "DEVICE" }, { "name": "Ibuprofen", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Ketorolac", "type": "DRUG" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Heron Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 63, "start_date": "2018-10-01", "completion_date": "2018-12-15", "has_results": true, "last_update_posted_date": "2026-03-02", "last_synced_at": "2026-10-09T04:39:59.555Z", "location_count": 5, "location_summary": "Anaheim, California • Pasadena, California • Draper, Utah + 2 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Pasadena", "state": "California" }, { "city": "Draper", "state": "Utah" }, { "city": "Murray", "state": "Utah" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT03695367" }, { "nct_id": "NCT07639723", "title": "Aprepitant to Improve Same Day Discharge for TKA", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "PONV" ], "interventions": [ { "name": "Aprepitant Injection", "type": "DRUG" }, { "name": "Ondansetron (Zofran)", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Endeavor Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 350, "start_date": "2026-07", "completion_date": "2027-08", "has_results": false, "last_update_posted_date": "2026-06-10", "last_synced_at": "2026-10-09T04:39:59.555Z", "location_count": 1, "location_summary": "Skokie, Illinois", "locations": [ { "city": "Skokie", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT07639723" }, { "nct_id": "NCT03237481", "title": "Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Postoperative Pain" ], "interventions": [ { "name": "HTX-011", "type": "DRUG" }, { "name": "Bupivacaine HCl", "type": "DRUG" }, { "name": "Saline placebo", "type": "DRUG" }, { "name": "Luer-lock applicator", "type": "DEVICE" }, { "name": "Vial access device", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Heron Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 418, "start_date": "2017-07-31", "completion_date": "2018-01-16", "has_results": true, "last_update_posted_date": "2026-03-02", "last_synced_at": "2026-10-09T04:39:59.555Z", "location_count": 22, "location_summary": "Florence, Alabama • Sheffield, Alabama • Phoenix, Arizona + 18 more", "locations": [ { "city": "Florence", "state": "Alabama" }, { "city": "Sheffield", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Bakersfield", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03237481" } ] }